133 related articles for article (PubMed ID: 35659720)
1. DTX-P7, a peptide-drug conjugate, is highly effective for non-small cell lung cancer.
Jiang Y; Huang W; Sun X; Yang X; Wu Y; Shi J; Zheng J; Fan S; Liu J; Wang J; Liang Z; Yang N; Liu Z; Liu Y
J Hematol Oncol; 2022 Jun; 15(1):73. PubMed ID: 35659720
[TBL] [Abstract][Full Text] [Related]
2. α
Zou Y; Sun Y; Guo B; Wei Y; Xia Y; Huangfu Z; Meng F; van Hest JCM; Yuan J; Zhong Z
ACS Appl Mater Interfaces; 2020 Apr; 12(13):14905-14913. PubMed ID: 32148016
[TBL] [Abstract][Full Text] [Related]
3. Enhanced antitumor effect on intrapulmonary tumors of docetaxel lung-targeted liposomes in a rabbit model of VX2 orthotopic lung cancer.
Wang L; Li R; Che K; Liu Z; Xiang S; Li M; Yu Y
Sci Rep; 2017 Aug; 7(1):10069. PubMed ID: 28855665
[TBL] [Abstract][Full Text] [Related]
4. Docetaxel-loaded exosomes for targeting non-small cell lung cancer: preparation and evaluation
Wang Y; Guo M; Lin D; Liang D; Zhao L; Zhao R; Wang Y
Drug Deliv; 2021 Dec; 28(1):1510-1523. PubMed ID: 34263685
[TBL] [Abstract][Full Text] [Related]
5. Enhanced in vivo antitumor efficacy of dual-functional peptide-modified docetaxel nanoparticles through tumor targeting and Hsp90 inhibition.
Jiang Y; Yang N; Zhang H; Sun B; Hou C; Ji C; Zheng J; Liu Y; Zuo P
J Control Release; 2016 Jan; 221():26-36. PubMed ID: 26643616
[TBL] [Abstract][Full Text] [Related]
6. Tumour targeted polymer nanoparticles co-loaded with docetaxel and siCCAT2 for combination therapy of lung cancer.
Xiao D; Hu X; Zhang J
J Drug Target; 2022 Jun; 30(5):534-543. PubMed ID: 34931561
[TBL] [Abstract][Full Text] [Related]
7. Cystine supplementation rebalances the redox homeostasis of microenvironment in non-small cell lung cancer cells and reverses their resistance to docetaxel.
Li SJ; Cao B; Lu ZY; Sun RB; Guo SH; Xie Y; Aa JY; Wang GJ
Acta Pharmacol Sin; 2021 Dec; 42(12):2132-2143. PubMed ID: 33658706
[TBL] [Abstract][Full Text] [Related]
8. Cetuximab-conjugated PLGA nanoparticles as a prospective targeting therapeutics for non-small cell lung cancer.
Kumari L; Ehsan I; Mondal A; Al Hoque A; Mukherjee B; Choudhury P; Sengupta A; Sen R; Ghosh P
J Drug Target; 2023 Jun; 31(5):521-536. PubMed ID: 37010248
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Antitumor Efficacy of Docetaxel-Loaded Monomethoxy Poly(ethylene glycol)-Poly(D, L-lactide-co-glycolide) Amphiphilic Copolymer Against Non-Small Cell Lung Cancer.
Lin Y; Zhuang X; Xie B; Chen H
J Nanosci Nanotechnol; 2020 Dec; 20(12):7263-7270. PubMed ID: 32711589
[TBL] [Abstract][Full Text] [Related]
10. Drug-interactive mPEG-
Gong F; Wang R; Zhu Z; Duan J; Teng X; Cui ZK
Drug Deliv; 2020 Dec; 27(1):238-247. PubMed ID: 32003299
[TBL] [Abstract][Full Text] [Related]
11. Circ_0003998 Regulates the Progression and Docetaxel Sensitivity of DTX-Resistant Non-Small Cell Lung Cancer Cells by the miR-136-5p/CORO1C Axis.
Zhang W; Song C; Ren X
Technol Cancer Res Treat; 2021; 20():1533033821990040. PubMed ID: 33511909
[TBL] [Abstract][Full Text] [Related]
12. [Preparation of docetaxel-loaded nanomicelles and their anti-Lewis lung cancer effect in vitro].
Wang YJ; Wang J; Hao DL; Yue QX; Xie R; DE GJ; Yi H; Zang C; Zhao QH; Chen YJ
Zhongguo Zhong Yao Za Zhi; 2019 Jun; 44(11):2251-2259. PubMed ID: 31359650
[TBL] [Abstract][Full Text] [Related]
13. Co-delivery of Docetaxel and Disulfonate Tetraphenyl Chlorin in One Nanoparticle Produces Strong Synergism between Chemo- and Photodynamic Therapy in Drug-Sensitive and -Resistant Cancer Cells.
Gaio E; Conte C; Esposito D; Miotto G; Quaglia F; Moret F; Reddi E
Mol Pharm; 2018 Oct; 15(10):4599-4611. PubMed ID: 30148955
[TBL] [Abstract][Full Text] [Related]
14. Chrysin Increases the Therapeutic Efficacy of Docetaxel and Mitigates Docetaxel-Induced Edema.
Lim HK; Kim KM; Jeong SY; Choi EK; Jung J
Integr Cancer Ther; 2017 Dec; 16(4):496-504. PubMed ID: 27151585
[TBL] [Abstract][Full Text] [Related]
15. Synergistic Antitumor Activity of SH003 and Docetaxel via EGFR Signaling Inhibition in Non-Small Cell Lung Cancer.
Jeong MS; Lee KW; Choi YJ; Kim YG; Hwang HH; Lee SY; Jung SE; Park SA; Lee JH; Joo YJ; Cho SG; Ko SG
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445110
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, characterization, and in vivo efficacy evaluation of PGG-docetaxel conjugate for potential cancer chemotherapy.
Yang D; Van S; Shu Y; Liu X; Ge Y; Jiang X; Jin Y; Yu L
Int J Nanomedicine; 2012; 7():581-9. PubMed ID: 22334784
[TBL] [Abstract][Full Text] [Related]
17.
Kazemi M; Emami J; Hasanzadeh F; Minaiyan M; Mirian M; Lavasanifar A; Mokhtari M
Recent Pat Anticancer Drug Discov; 2020; 15(4):341-359. PubMed ID: 33023456
[TBL] [Abstract][Full Text] [Related]
18. Co-Delivery of Docetaxel and Curcumin via Nanomicelles for Enhancing Anti-Ovarian Cancer Treatment.
Hu Y; Ran M; Wang B; Lin Y; Cheng Y; Zheng S
Int J Nanomedicine; 2020; 15():9703-9715. PubMed ID: 33299312
[TBL] [Abstract][Full Text] [Related]
19. Facile fabrication of robust, hyaluronic acid-surfaced and disulfide-crosslinked PLGA nanoparticles for tumor-targeted and reduction-triggered release of docetaxel.
Wang X; Cheng R; Zhong Z
Acta Biomater; 2021 Apr; 125():280-289. PubMed ID: 33677162
[TBL] [Abstract][Full Text] [Related]
20. In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration.
Lee E; Kim H; Lee IH; Jon S
J Control Release; 2009 Dec; 140(2):79-85. PubMed ID: 19712714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
